4.6 Article

Functionalized selenium nanoparticles with nephroprotective activity, the important roles of ROS-mediated signaling pathways

Journal

JOURNAL OF MATERIALS CHEMISTRY B
Volume 1, Issue 46, Pages 6365-6372

Publisher

ROYAL SOC CHEMISTRY
DOI: 10.1039/c3tb21168a

Keywords

-

Funding

  1. National Science and Technology Support Program [2012BAC07B05]
  2. Science Foundation for Distinguished Young Scholars of Guangdong Province
  3. Natural Science Foundation of China and Guangdong Province
  4. Program for New Century Excellent Talents in University
  5. Research Fund for the Doctoral Program of Higher Education of China
  6. China Postdoctoral Science Foundation

Ask authors/readers for more resources

The most frequent adverse effect of cisplatin-based chemotherapy is nephrotoxicity. Oxidative stress has been implicated as an important mechanism in the pathogenesis of cisplatin-induced nephrotoxicity. In the present study, 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid (trolox) surface-functionalized selenium nanoparticles (Se@Trolox) with enhanced antioxidant activity have been prepared by self-assembly of trolox on the surface of the nanoparticles, and their nephroprotective effects have been investigated. Functionalization by trolox significantly enhanced cell uptake and in vitro antioxidant activities of the nanoparticles. In addition, pretreatment with Se@Trolox dose-dependently blocked cisplatin-induced cell growth inhibition against HK-2 cells. Mechanistic investigation suggested that Se@Trolox markedly prevented cisplatin-induced apoptosis in HK-2 cells, as evidenced by inhibition of chromatin condensation, DNA fragmentation, PARP cleavage and activation of caspase-3. Furthermore, Se@Trolox effectively blocked the cisplatin-induced reactive oxygen species (ROS) accumulation, activation of AKT and MAPK signaling and DNA damage-mediated p53 phosphorylation in HK-2 cells. Taken together, our findings suggest that Se@Trolox is a promising Se species with potential application in prevention of cisplatin-induced renal injury.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available